Haijiao C. Yan

185 Juqian Street
Changzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

PODXL2 Promotes Cholangiocarcinoma Progression via Interactions with Ezrin and Activation of the MAPK/ERK1/2 and PI3K/AKT Signaling Pathways.

PODXL2 Promotes Cholangiocarcinoma Progression via Interactions with Ezrin and Activation of the MAPK/ERK1/2 and PI3K/AKT Signaling Pathways.

Journal: Digestive diseases and sciences

Published: November 07, 2025

S100 Calcium-Binding Protein P and Cathepsin E as Key Mediators in Pancreatic Cancer Tumorigenesis.

S100 Calcium-Binding Protein P and Cathepsin E as Key Mediators in Pancreatic Cancer Tumorigenesis.

Journal: Biomedicines

Published: September 04, 2025

The Role and Function of Non-Coding RNAs in Cholangiocarcinoma Invasiveness.

The Role and Function of Non-Coding RNAs in Cholangiocarcinoma Invasiveness.

Journal: Biomedicines

Published: April 13, 2025

Mecapegfilgrastim prophylaxis for neutropenia in patients with non-myeloid malignancies: A Chinese nationwide real-world study.

Mecapegfilgrastim prophylaxis for neutropenia in patients with non-myeloid malignancies: A Chinese nationwide real-world study.

Journal: BMC cancer

Published: February 18, 2025

IL-21 and IL-33 May Be Effective Biomarkers to Predict the Efficacy of PD-1 Monoclonal Antibody for Advanced Cholangiocarcinoma.

IL-21 and IL-33 May Be Effective Biomarkers to Predict the Efficacy of PD-1 Monoclonal Antibody for Advanced Cholangiocarcinoma.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: January 21, 2025

Retraction: MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway.

Retraction: MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway.

Journal: Oncotarget

Published: January 20, 2025

Safety and efficacy of mecapegfilgrastim in preventing neutropenia in patients with head and neck cancer: a multicenter, prospective, observational, real-world study.

Safety and efficacy of mecapegfilgrastim in preventing neutropenia in patients with head and neck cancer: a multicenter, prospective, observational, real-world study.

Journal: Translational cancer research

Published: October 21, 2024

A multicenter, prospective, non-interventional real-world study to assess the effectiveness of mecapegfilgrastim in preventing neutropenia in patients with gastrointestinal cancer.

A multicenter, prospective, non-interventional real-world study to assess the effectiveness of mecapegfilgrastim in preventing neutropenia in patients with gastrointestinal cancer.

Journal: Immunity, inflammation and disease

Published: January 08, 2024

Circulating tumor cells in gastric cancer: developments and clinical applications.

Circulating tumor cells in gastric cancer: developments and clinical applications.

Journal: Clinical and experimental medicine

Published: February 16, 2023

Prophylaxis of neutropenia with mecapegfilgrastim in patients with non-myeloid malignancies: a real-world study.

Prophylaxis of neutropenia with mecapegfilgrastim in patients with non-myeloid malignancies: a real-world study.

Journal: Annals of translational medicine

Published: June 24, 2021

The Prognostic Value of the Prognostic Nutritional Index (PNI) in Radically Resected Esophagogastric Junction Adenocarcinoma.

The Prognostic Value of the Prognostic Nutritional Index (PNI) in Radically Resected Esophagogastric Junction Adenocarcinoma.

Journal: Nutrition and cancer

Published: November 02, 2020

Circulating tumor DNA detection and its application status in gastric cancer: a narrative review.

Circulating tumor DNA detection and its application status in gastric cancer: a narrative review.

Journal: Translational cancer research

Published: September 08, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026